We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Expected fall highlights challenges for pharmaceutical companies that experienced pandemic windfall
An analysis of the potential of technology to transform personalised medicine is both stimulating and comprehensive
Global health body urges increased vigilance to reduce transmission of deadly disease
Swiss group rethinks NHS collaboration after low take-up of treatment during rollout via GPs
Health body says genetic sequences are not definitive and all origin theories, including lab leak, remain on table
Unexpected finding suggests popular sweetener could treat autoimmune conditions such as arthritis and diabetes
UK biotech Awakn licences ‘party drug’ to addiction clinics
Unequal access to jabs in 2021 led to one preventable death every 24 seconds, politicians and activists say
Therapies based on editing of human genomes predicted to have a price tag of $2mn per patient
Government later says no ‘evidence’ of attempted hacking of NHS genetic data centre by BGI
The country dismantled its precautionary measures as quickly as they sprang up — but not at the National People’s Congress
Study identifies new stomach disease in seabirds caused by microplastics
Fifty organisations form coalition to counter dangerous falsehoods and rebuild trust in science
The new cold war makes another pandemic more likely
Proposal for ‘intelligence in a dish’ that can efficiently perform advanced tasks raises ethical concerns
Scientists urge more vigorous action to reduce circulation of highly contagious H5N1 strain
Pharma group hopes for approval of mRNA vaccine for booster shots
Pharma chief says sector is seen as ‘niche’ and leaves women suffering from healthcare inequality
Experts believe bacteriophages could be crucial extra tool
Researchers say device developed in London could help thousands suffering from vascular disease
Neuroscience breakthrough demonstrates ability of human organoids to adopt functions of host’s visual cortex
UK biotech racing to keep antibody up to date with latest variants
Short-termism and suspicion in parts of government risk our valuable future in precision medicine
Future of pandemic less predictable than at the outset because of new variants, says Jenny Harries
For all its landmark status, lecanemab may end up representing a triumph of hope over evidence
International Edition
